Cargando…
Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
AIMS: The aim of this article is to review the safety and efficacy data of dapagliflozin, saxagliptin, and their combination in the management of patients with type 2 diabetes. Evidence for the use of the single-tablet combination formulation is also presented. METHODS: A nonsystematic literature re...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533573/ https://www.ncbi.nlm.nih.gov/pubmed/28769579 http://dx.doi.org/10.2147/DMSO.S117982 |